Adam P Silverman

Title: Innovations by Adam P Silverman

Introduction

Adam P Silverman is an accomplished inventor based in San Carlos, California. He has made significant contributions to the field of biotechnology, particularly in the development of engineered polypeptides. His work focuses on enhancing the therapeutic potential of enzymes, which can have a profound impact on medical treatments.

Latest Patents

Adam P Silverman holds a patent for "Engineered acid alpha-glucosidase variants." This invention provides engineered acid alpha-glucosidase (GAA) polypeptides and compositions thereof. The engineered GAA polypeptides have been optimized to offer increased expression, stability at neutral pH, and activity in cell lysates. Additionally, the invention outlines methods for utilizing these compositions for therapeutic and other purposes.

Career Highlights

Adam is currently associated with Codexis, Inc., a company known for its innovative approaches in enzyme technology. His work at Codexis has allowed him to explore the potential of engineered enzymes in various applications, contributing to advancements in the biotechnology sector.

Collaborations

Throughout his career, Adam has collaborated with notable colleagues, including William Casey Hallows and Rachel Cathleen Botham. These collaborations have fostered a dynamic environment for innovation and research.

Conclusion

Adam P Silverman exemplifies the spirit of innovation in biotechnology through his patented work on engineered acid alpha-glucosidase variants. His contributions not only advance scientific knowledge but also hold promise for therapeutic applications.